International Psoriasis Council

Advancing Knowledge. Improving Care.

Banner with ESDR, IEC, and IPC logos on the left, highlighting eczema research at the 55th Annual ESDR Meeting Heidelberg, Germany. A photo on the right shows Heidelberg with the Neckar River and historic stone bridge.

IEC-IPC Eczema and Psoriasis Research Incubator: Cross-Disciplinary Innovation Forum

55TH ANNUAL EUROPEAN SOCIETY FOR INVESTIGATIVE DERMATOLOGICAL RESEARCH MEETING (ESDR) | HEIDELBERG, GERMANY

September 9, 2026
 | 08:00–12:00 CEST
Location: Heidelberg Congress Center | Hall 2A, Level 1

Add this event to your calendar

Apple Google Outlook Outlook.com Office 365 Yahoo

The IEC–IPC Eczema and Psoriasis Research Incubator is a pre-congress, interactive forum designed to catalyze cross-disciplinary collaboration and accelerate innovation across inflammatory skin diseases. Featuring keynote presentations from global thought leaders, the program moves from cutting-edge insights into disease mechanisms and precision stratification to data-driven, translational approaches that inform real-world practice. Participants will engage in rapid-fire early-career presentations and structured small-group “Challenge Labs” focused on priority research themes, with the goal of identifying actionable gaps and shaping collaborative project concepts. This highly interactive format emphasizes practical outcomes, new partnerships, and sustained engagement beyond the session. Early-career investigators are strongly encouraged to apply.

Registration for the ESDR Congress is required to attend the IEC-IPC Program on Wednesday, September 9, 2026. 

Agenda

Registration and Breakfast

Welcome & Framing Remarks
Sara Brown, MBChB, MD, United Kingdom and Curdin Conrad, MD, Switzerland

KEYNOTE: From Mechanism to Precision: Defining Disease Endotypes
Johann Gudjonsson, MD, PhD, United States

KEYNOTE: From Data to Impact: Translating Evidence into Practice
Satveer Mahil, PhD, FRCP, United Kingdom

Lightning Talks: Early-Career Investigator Spotlights

BREAK

Challenge Labs: Small Group Innovation Sessions

  • Shared Comorbidities – Facilitators: Anna López-Ferrer, MD, PhD and Caroline Mann, MD
  • Mechanisms of Disease – Facilitators: Claus Johansen, MSc, PhD, DMSc and Danuta Gutowska-Owsiak, MD, PhD, DSc
  • Endotypes – Facilitator: Paola Di Meglio, PhD
  • Treatment Stratification – Facilitators: Andreas Pinter, MD, PhD and Nick Reynolds, BSc, MBBS, MD, FRCP
  • Precision Medicine – Facilitators: Nicole Ward, PhD and John Common, PhD
  • Paradoxical Cases – Facilitator: Johann Gudjonsson, MD, PhD
  • Global Challenges – Facilitator: Chris Griffiths, OBE, MD, FMedSci

Report-Outs & Expert Commentary Panel

Closing Reflections & Next Steps

Program Chairs

Sara Brown, MBChB, MD

University of Edinburgh

Edinburgh, Scotland, United Kingdom

Bio

Johann Gudjonsson, MD, PhD

University of Michigan, Department of Dermatology

Ann Arbor, Michigan, United States

IPC Board Member

Bio

Fernando Valenzuela, MD

University of Chile, University of the Andes

Santiago, Chile

IPC Councilor

Bio

Nicole Ward, PhD

Vanderbilt University Medical Center

Nashville, Tennessee, United States

IPC Councilor

Bio

Program Faculty

John Edmund Armourer Common, PhD

Newcastle University

Newcastle upon Tyne, United Kingdom

Bio

Curdin Conrad, MD

University Hospital of Lausanne

Lausanne, Switzerland

IPC Board Member

Bio

Paola Di Meglio, PhD

King’s College London

London, United Kingdom

IPC Councilor

Bio

Christopher Griffiths, OBE, MD, FMedSci

University of Manchester and King’s College London

London, United Kingdom

IPC Honorary Founder

Bio

Danuta Gutowska-Owsiak, MD, PhD, DSc

University of Gdańsk

Gdańsk, Poland

Bio

Claus Johansen, MSc, PhD, DMSc

Aarhus University Hospital

Aarhus, Denmark

IPC Councilor

Bio

Anna López Ferrer, MD, PhD

Hospital de la Santa Creu i Sant Pau

Barcelona, Spain

IPC Councilor

Bio

Caroline Mann, MD

University Medical Center of the Johannes Gutenberg University

Mainz, Germany

Bio

Satveer Mahil, PhD, FRCP

St John’s Institute of Dermatology

London, United Kingdom

IPC Councilor

Bio

Andreas Pinter, MD, PhD

University Hospital Frankfurt

Frankfurt, Germany

IPC Councilor

Bio

Nick Reynolds, BSc, MBBS, MD, FRCP

Newcastle University

Newcastle upon Tyne, United Kingdom

IPC Councilor

Bio

This program is supported in part by

A line drawing of a lion walking above the word LEO with a horizontal line underneath, and LEO FOUNDATION written in large capital letters below, symbolizing strength and dedication to advancing eczema research.

What's New

Videos Now Available from the IPC Symposium at SID Chicago

Did you miss the IPC symposium at the 83rd Society for Investigative Dermatology (SID) Annual Meeting? Select session videos are now available. The Arc of Disease Control in Psoriasis: Early Interception – Deep Pathway Blockade – Treatment Failure covered early intervention strategies, treatment selection, immune pathway targeting, PsA prevention, clinical escape, and real-world cases that inform long-term psoriasis care.

WATCH NOW

Wednesday, June 17, 2026

Take Ten: Mio Nakamura – Psoriasis and Mental Health

Depression affects approximately 20% of patients with psoriasis, five times the rate seen in the general population. IPC Jr. Councilor Mio Nakamura, MD, MS, FAAD, walks through the bidirectional relationship between psoriasis and depression, the shared inflammatory pathways driving both conditions, and practical guidance on screening and incorporating multidisciplinary mental health support into psoriasis management.

WATCH NOW

Thursday, June 11, 2026